<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nid</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология и диализ</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology and Dialysis</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1680-4422</issn><issn pub-type="epub">2618-9801</issn><publisher><publisher-name>Российское диализное общество</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.28996/2618-9801-2022-3-494-501</article-id><article-id custom-type="elpub" pub-id-type="custom">nid-85</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Выявление факторов риска развития туберкулеза органов дыхания среди больных хронической болезнью почек в терминальной стадии</article-title><trans-title-group xml:lang="en"><trans-title>Risk factors identification of respiratory tuberculosis progression in patients with end-stage renal disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гордеева</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Gordeeva</surname><given-names>O. M.</given-names></name></name-alternatives><email xlink:type="simple">o.gordeeva@ctri.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карпина</surname><given-names>Н. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Karpina</surname><given-names>N. L.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Центральный научно-исследовательский институт туберкулеза»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Scientific Institution "Central TB Research Institute" (FSBSI "Central TB Research Institute")</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>21</day><month>06</month><year>2024</year></pub-date><volume>24</volume><issue>3</issue><fpage>494</fpage><lpage>501</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гордеева О.М., Карпина Н.Л., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Гордеева О.М., Карпина Н.Л.</copyright-holder><copyright-holder xml:lang="en">Gordeeva O.M., Karpina N.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephro.ru/jour/article/view/85">https://journal.nephro.ru/jour/article/view/85</self-uri><abstract><p>Поиск предикторов реактивации туберкулеза у больных хронической болезнью почек в терминальной стадии (ТХБП) - неотъемлемая часть современного обследования больных, получающих заместительную терапию, в том числе кандидатов на трансплантацию почки. В данной статье впервые на статистически значимой выборке представлены результаты изучения взаимосвязи основных клинико-анамнестических факторов риска развития активного туберкулеза у больных на диализе. Проведен анализ клинико-анамнестических характеристик 105 пациентов с ТХБП обследованных в ФГБНУ «ЦНИИТ» с 2010 по 2020 г. по поводу интоксикационного синдрома неясного генеза и/или впервые выявленных изменений в органах грудной клетки. По итогам комплексного обследования всем больным ТХБП были установлены диагнозы, среди которых преобладала туберкулезная инфекция 62/105 человек (59%), у 43/105 человек (41%) были диагностированы различные заболевания органов дыхания нетуберкулезной этиологии. Проведен анализ следующих данных: возраст и пол больного, индекс массы тела пациента, этиология заболевания почек, курсы лечения заболевания почек до заместительной терапии, нефрэктомия в анамнезе, срок получения первичной заместительной терапии, наличие сопутствующей патологии, вид сопутствующей патологии, фтизиатрический анамнез, срок от начала уремии до развития заболевания органов дыхания и их корреляционной связи с этиологией заболевания органов дыхания, выявленного по результатам обследования в ФГБНУ «ЦНИИТ». Установлено, что несмотря на то, что по данным различных авторов ранее такие факторы как пол, причина уремии, срок заместительной терапии были выделены как предикторы развития туберкулеза у больных на диализе, на данный момент ни один из исследуемых признаков не имеет статистически значимой корреляционной связи с этиологией заболевания органов дыхания у больных на диализе. Вне зависимости от пола, возраста, индекса массы тела (ИМТ), причины развития почечной недостаточности, числа сопутствующих заболеваний и сроков наблюдения больные ТХБП остаются в группе высокого риска развития туберкулеза.</p></abstract><trans-abstract xml:lang="en"><p>Predictor’s study of tuberculosis reactivation among patients with end-stage renal disease (ESRD) is a vital part of recent medical examination for patients who undergo substitution therapy, including candidates for kidney transplantation. In this article, for the first time on a statistically significant sample, we presented the results of studying the relationship between the main clinical and anamnestic risk factors for the development of active tuberculosis in dialysis patients. The analysis of the clinical and anamnestic characteristics of 105 patients with ESRD examined at FSBSI "Central TB Research Institute" with intoxication syndrome of unknown origin and/or newly identified changes in the organs of the chest from 2010 to 2020 was carried out. Based on the results of a comprehensive examination, 62/105 of ESRD patients (59%), were diagnosed with tuberculosis infection -respiratory diseases of non-tuberculous etiology - 43/105 people (41%). The following data were analyzed: the patient's age and sex, the patient's body mass index, the etiology of kidney disease, the presence of treatment for kidney disease before substitution therapy, nephrectomy in the anamnesis, the period of receiving primary substitution therapy, the presence of concomitant pathology, the type of concomitant pathology, tuberculosis history, the period from the onset of uremia before the development of respiratory diseases and their correlation with the etiology of the respiratory diseases, identified based on the results of examination at FSBSI "Central TB Research Institute". It was found that even though, according to various authors, previously such factors as gender, the cause of uremia, and the duration of substitution therapy were identified as predictors of the development of tuberculosis in patients on dialysis, now none of the studied signs has a statistically significant correlation with etiology of respiratory diseases in patients on dialysis. Regardless of gender, age, body mass index (BMI), the cause of renal failure, the number of concomitant diseases, and the duration of follow-up, TCKD patients remain at a high risk of developing active tuberculosis</p></trans-abstract><kwd-group xml:lang="ru"><kwd>туберкулез органов дыхания</kwd><kwd>хроническая болезнь почек</kwd><kwd>гемодиализ</kwd><kwd>факторы риска</kwd><kwd>pulmonary tuberculosis</kwd><kwd>ESRD</kwd><kwd>hemodialysis</kwd><kwd>risk factors</kwd><kwd>diagnosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Okada R., Barry P., Skarbinski J., &amp; Chitnis A. Epidemiology, detection, and management of tuberculosis among end-stage renal disease patients. Infection Control &amp; Hospital Epidemiology. 2018; 39 (11): 1367-1374. doi: 10.1017/ice.2018.219.</mixed-citation><mixed-citation xml:lang="en">Okada R., Barry P., Skarbinski J., &amp; Chitnis A. Epidemiology, detection, and management of tuberculosis among end-stage renal disease patients. Infection Control &amp; Hospital Epidemiology. 2018; 39 (11): 1367-1374. doi: 10.1017/ice.2018.219.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Simon T., Paul S., Wartenberg D., &amp; Tokars J. Tuberculosis in Hemodialysis Patients in New Jersey: A Statewide Study. Infection Control &amp; Hospital Epidemiology. 1999; 20(9): 607-609. doi: 10.1086/501679.</mixed-citation><mixed-citation xml:lang="en">Simon T., Paul S., Wartenberg D., &amp; Tokars J. Tuberculosis in Hemodialysis Patients in New Jersey: A Statewide Study. Infection Control &amp; Hospital Epidemiology. 1999; 20(9): 607-609. doi: 10.1086/501679.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Romanowski K., Clark E. G., Levin A. et al. Tuberculosis and chronic kidney disease:an emerging global syndemic. Kidney International. 2016; 90: 34-40. doi: 10.1016/j.kint.2016.01.034.</mixed-citation><mixed-citation xml:lang="en">Romanowski K., Clark E. G., Levin A. et al. Tuberculosis and chronic kidney disease:an emerging global syndemic. Kidney International. 2016; 90: 34-40. doi: 10.1016/j.kint.2016.01.034.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ruzangi et al. The association between chronic kidney disease and tuberculosis; a comparative cohort study in England. BMC Nephrology. 2020; 21: 420. doi: 10.1186/s12882-020-02065-4.</mixed-citation><mixed-citation xml:lang="en">Ruzangi et al. The association between chronic kidney disease and tuberculosis; a comparative cohort study in England. BMC Nephrology. 2020; 21: 420. doi: 10.1186/s12882-020-02065-4.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Min J., Kwon S.K., Jeong H.W. et al. End-stage Renal Disease and Risk of Active Tuberculosis: a Nationwide Population-Based Cohort Study. J Korean Med Sci. 2018; Dec 31; 33(53): e341 doi:10.3346/jkms.2018.33.e341.</mixed-citation><mixed-citation xml:lang="en">Min J., Kwon S.K., Jeong H.W. et al. End-stage Renal Disease and Risk of Active Tuberculosis: a Nationwide Population-Based Cohort Study. J Korean Med Sci. 2018; Dec 31; 33(53): e341 doi:10.3346/jkms.2018.33.e341.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Андрусев А.М., Томилина Н.А., Перегудова Н.Г. и др. Заместительная почечная терапия хрони ческой болезни почек 5 стадии в Российской Федерации 2015-2019 гг. Отчет по данным Общероссийского Регистра заместительной почечной терапии Российского диализного общества. Нефрология и диализ. 2021; 23(3): 255-329. doi: 10.28996/ 2618-9801-2021-3-255-329.</mixed-citation><mixed-citation xml:lang="en">Андрусев А.М., Томилина Н.А., Перегудова Н.Г. и др. Заместительная почечная терапия хрони ческой болезни почек 5 стадии в Российской Федерации 2015-2019 гг. Отчет по данным Общероссийского Регистра заместительной почечной терапии Российского диализного общества. Нефрология и диализ. 2021; 23(3): 255-329. doi: 10.28996/ 2618-9801-2021-3-255-329.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Saran R., Robinson B., Abbott K.C. et al. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2019; 73 (3 Suppl 1): A7-A8. doi: 10.1053/j.ajkd.2019.01.001.</mixed-citation><mixed-citation xml:lang="en">Saran R., Robinson B., Abbott K.C. et al. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2019; 73 (3 Suppl 1): A7-A8. doi: 10.1053/j.ajkd.2019.01.001.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lee T., Flythe J. E., Allon M. Dialysis Care around the World: A Global Perspectives Series. Kidney 360. 2021; 2 (4) 604-607. doi: 10.34067/KID.0001082021.</mixed-citation><mixed-citation xml:lang="en">Lee T., Flythe J. E., Allon M. Dialysis Care around the World: A Global Perspectives Series. Kidney 360. 2021; 2 (4) 604-607. doi: 10.34067/KID.0001082021.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Shohaib S.A., Scrimgeour E.M., Shaerya F. Tuberculosis in active dialysis patients in Jeddah. Am J Nephrol 1999; 19: 34-7 doi: 10.1159/000013422.</mixed-citation><mixed-citation xml:lang="en">Shohaib S.A., Scrimgeour E.M., Shaerya F. Tuberculosis in active dialysis patients in Jeddah. Am J Nephrol 1999; 19: 34-7 doi: 10.1159/000013422.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Christopoulos A.I., Diamantopoulos A.A., Dimopoulos P.A. et al. Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trial. BMC Nephrol. 2009; 10: 36 doi: 10.1186/1471-2369-10-36.</mixed-citation><mixed-citation xml:lang="en">Christopoulos A.I., Diamantopoulos A.A., Dimopoulos P.A. et al. Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trial. BMC Nephrol. 2009; 10: 36 doi: 10.1186/1471-2369-10-36.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Rao T.M., Ram R., Swarnalatha G. et al. Tuberculosis in haemodialysis patients: A single centre experience. Indian J Nephrol. 2013; 23: 340-345. doi: 10.4103/0971-4065.116296.</mixed-citation><mixed-citation xml:lang="en">Rao T.M., Ram R., Swarnalatha G. et al. Tuberculosis in haemodialysis patients: A single centre experience. Indian J Nephrol. 2013; 23: 340-345. doi: 10.4103/0971-4065.116296.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Chou K.J., Fang H.C., Bai K.J. et al. Tuberculosis in maintenance dialysis patients. Nephron. 2001; 88: 138-43. doi: 10.1159/000045974.</mixed-citation><mixed-citation xml:lang="en">Chou K.J., Fang H.C., Bai K.J. et al. Tuberculosis in maintenance dialysis patients. Nephron. 2001; 88: 138-43. doi: 10.1159/000045974.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Mitwalli A. Tuberculosis in patients on maintenance dialysis. Am J Kidney Dis. 1991; 18: 579-582. doi: 10.1016/s0272-6386(12)80653-6.</mixed-citation><mixed-citation xml:lang="en">Mitwalli A. Tuberculosis in patients on maintenance dialysis. Am J Kidney Dis. 1991; 18: 579-582. doi: 10.1016/s0272-6386(12)80653-6.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Moreiras-Plaza M., Pazos B., Courel M.A. et al. Tuberculosis in dialysis patients. Nefrologia. 1995; 15: 581-586.</mixed-citation><mixed-citation xml:lang="en">Moreiras-Plaza M., Pazos B., Courel M.A. et al. Tuberculosis in dialysis patients. Nefrologia. 1995; 15: 581-586.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
